Bioavailability profile of Uceris MMX extended-release tablets compared with Entocort EC capsules in healthy volunteers.
about
Budesonide Multi-matrix for the Treatment of Patients with Ulcerative ColitisColon-targeted oral drug delivery systems: design trends and approachesBudesonide MMX(®): a review of its use in patients with mild to moderate ulcerative colitis.Novel extended release budesonide formulation for treatment of ulcerative colitis.Biopharmaceutical considerations and characterizations in development of colon targeted dosage forms for inflammatory bowel disease.Budesonide for the treatment of ulcerative colitis.
P2860
Bioavailability profile of Uceris MMX extended-release tablets compared with Entocort EC capsules in healthy volunteers.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Bioavailability profile of Uce ...... apsules in healthy volunteers.
@en
Bioavailability profile of Uce ...... apsules in healthy volunteers.
@nl
type
label
Bioavailability profile of Uce ...... apsules in healthy volunteers.
@en
Bioavailability profile of Uce ...... apsules in healthy volunteers.
@nl
prefLabel
Bioavailability profile of Uce ...... apsules in healthy volunteers.
@en
Bioavailability profile of Uce ...... apsules in healthy volunteers.
@nl
P2093
P2860
P356
P1476
Bioavailability profile of Uce ...... apsules in healthy volunteers.
@en
P2093
Andrew Nicholls
Luigi Moro
Michael Huang
Raúl Harris-Collazo
Richard Jones
Yun Hardiman
P2860
P304
P356
10.1177/0300060513476588
P577
2013-03-07T00:00:00Z